We are live on ! Find out more
Marshall Wace

Marshall Wace Portfolio holdings

AUM $100B
1-Year Est. Return 35.1%
This Fund
S&P 500
This Quarter Est. Return
+6.74%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$6.79B
AUM Growth
+$1.29B
Cap. Flow
+$933M
Cap. Flow %
13.74%
Top 10 Hldgs %
15.83%
Holding
1,205
New
433
Increased
209
Reduced
253
Closed
295

Top Buys

Rank Stock Value
1
LAZ icon
Lazard
LAZ
+$67.3M
2
PPG icon
PPG Industries
PPG
+$49.7M
3
AAPL icon
Apple
AAPL
+$46.8M
4
MU icon
Micron Technology
MU
+$42.1M
5
HRB icon
H&R Block
HRB
+$41.7M

Sector Composition

Rank Sector Weight
1 Industrials 12.8%
2 Communication Services 12.26%
3 Healthcare 12.21%
4 Materials 11.4%
5 Financials 11.01%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TUMI
201
DELISTED
TUMI HLDGS INC COM
TUMI
$8.17M 0.12%
406,002
+193,737
+91% +$3.91M
NBIS
202
Nebius Group N.V.
NBIS
$47.7B
$8.05M 0.12%
225,773
-101,550
-31% -$3.12M
AZN icon
203
AstraZeneca
AZN
$263B
$8.04M 0.12%
108,220
-366,345
-77% -$26.5M
COV
204
DELISTED
COVIDIEN PLC COM SHS NEW (IRELAND)
COV
$8M 0.12%
+88,726
New +$6.64M
LLTC
205
DELISTED
Linear Technology Corp
LLTC
$7.95M 0.12%
+168,988
New +$7.83M
PSX icon
206
Phillips 66
PSX
$82.9B
$7.92M 0.12%
+98,476
New +$8.11M
STLD icon
207
Steel Dynamics
STLD
$35.6B
$7.92M 0.12%
441,175
+418,275
+1,827% +$7.52M
PLL
208
DELISTED
PALL CORP
PLL
$7.91M 0.12%
+92,586
New +$7.92M
HAWK
209
DELISTED
Blackhawk Network Holdings, Inc. Common Stock
HAWK
$7.84M 0.12%
+284,701
New +$7.06M
MEI icon
210
Methode Electronics
MEI
$543M
$7.81M 0.12%
204,480
+40,369
+25% +$1.23M
MWIV
211
DELISTED
MWI VETERINARY SUPPLY, INC.
MWIV
$7.78M 0.11%
54,816
+36,378
+197% +$5.34M
CSTE icon
212
Caesarstone
CSTE
$72.3M
$7.73M 0.11%
+157,423
New +$8.01M
SONC
213
DELISTED
Sonic Corp
SONC
$7.61M 0.11%
+344,700
New +$7.27M
GIII icon
214
G-III Apparel Group
GIII
$1.47B
$7.57M 0.11%
+185,340
New +$6.99M
LSI
215
DELISTED
Life Storage, Inc.
LSI
$7.54M 0.11%
146,307
-124,497
-46% -$6.3M
MYCC
216
DELISTED
ClubCorp Holdings, Inc.
MYCC
$7.53M 0.11%
406,300
+333,545
+458% +$6.13M
GIL icon
217
Gildan
GIL
$9.25B
$7.48M 0.11%
253,926
-11,600
-4% -$310K
PL
218
DELISTED
PROTECTIVE LIFE CORP
PL
$7.37M 0.11%
+106,294
New +$6.05M
PBH icon
219
Prestige Consumer Healthcare
PBH
$2.35B
$7.33M 0.11%
+216,343
New +$6.93M
CVS icon
220
CVS Health
CVS
$137B
$7.33M 0.11%
+97,185
New +$7.34M
IPXL
221
DELISTED
Impax Laboratories, Inc.
IPXL
$7.27M 0.11%
+242,396
New +$6.54M
DTV
222
DELISTED
DIRECTV COM STK (DE)
DTV
$7.23M 0.11%
85,102
-29,967
-26% -$2.44M
HPY
223
DELISTED
HEARTLAND PAYMENT SYSTEMS, INC. COM STK
HPY
$7.12M 0.1%
+172,666
New +$7.02M
AXP icon
224
American Express
AXP
$223B
$6.97M 0.1%
+73,478
New +$6.62M
PTC icon
225
PTC
PTC
$13.7B
$6.93M 0.1%
+178,718
New +$6.44M

Similar funds

Marshall Wace's Q2 2014 Portfolio in Review

As of Q2 2014, Marshall Wace held 1,205 positions worth $6.79B, up 24% from $5.5B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

Marshall Wace deployed $933M of net new capital in Q2 2014, opening 433 new positions and adding to 209 existing holdings. Its largest new stake was H&R Block: 1,400,000 shares worth $46.9M.

By sector, the portfolio is most concentrated in Industrials at 13% of assets, up from 13% a quarter earlier, followed by Communication Services and Healthcare.

On the sell side, the largest reduction was SANDISK CORP, an estimated $35.8M trimmed.

  • Marshall Wace's largest Q2 2014 buy was H&R Block: 1,400,000 shares worth $46.9M.
  • Marshall Wace added most to Lazard in Q2 2014, an estimated $67.3M increase.
  • Marshall Wace's biggest Q2 2014 reduction was SANDISK CORP, cutting an estimated $35.8M.
  • Marshall Wace fully exited SANTANDER CONSUMER USA HOLDINGS INC in Q2 2014, selling an estimated $54.9M.
  • Marshall Wace's ten largest holdings make up 16% of its $6.79B portfolio in Q2 2014.
  • Marshall Wace opened 433 new positions and closed 295 in Q2 2014.
  • Marshall Wace's portfolio value rose 24% quarter-over-quarter to $6.79B.

Based on Marshall Wace's 13F filing for Q2 2014, filed 14 Aug 2014.